HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jill M Kolesar Selected Research

3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)

10/2010The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.
2/2010A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
5/2009A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
4/2008Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jill M Kolesar Research Topics

Disease

25Neoplasms (Cancer)
06/2015 - 08/2002
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2015 - 07/2005
7Breast Neoplasms (Breast Cancer)
08/2012 - 03/2006
5Fatigue
04/2014 - 04/2009
5Diarrhea
05/2013 - 11/2006
4Nausea
03/2014 - 08/2005
4Multiple Myeloma
12/2012 - 01/2009
4Neutropenia
12/2010 - 11/2006
3Thrombocytopenia (Thrombopenia)
11/2011 - 05/2009
3Colorectal Neoplasms (Colorectal Cancer)
11/2010 - 11/2006
2Vomiting
03/2014 - 08/2005
2Renal Cell Carcinoma (Grawitz Tumor)
03/2014 - 01/2008
2Peripheral Nervous System Diseases (PNS Diseases)
02/2014 - 01/2014
2Hypertension (High Blood Pressure)
05/2013 - 01/2008
2Disease Progression
04/2013 - 05/2010
2Polycythemia Vera
12/2012 - 03/2008
2Infection
11/2011 - 03/2007
2Pruritus (Itching)
12/2010 - 09/2005
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2010 - 08/2005
2Hematologic Neoplasms (Hematological Malignancy)
01/2009 - 09/2005
1Adenocarcinoma
09/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2015
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2014
1Fever (Fevers)
04/2014
1Pain (Aches)
01/2014
1Melanoma (Melanoma, Malignant)
07/2013
1Hypogonadism (Hypergonadotropic Hypogonadism)
06/2013
1Torsades de Pointes (Torsade de Pointes)
05/2013
1Exanthema (Rash)
05/2013
1Long QT Syndrome
05/2013
1Headache (Headaches)
05/2013
1Heart Failure
05/2013
1Bradycardia
05/2013
1Head and Neck Neoplasms (Head and Neck Cancer)
04/2013
1Primary Myelofibrosis (Myelosclerosis)
12/2012
1Gilbert Disease
12/2012
1Endometrial Neoplasms (Endometrial Cancer)
08/2012
1Cataract (Cataracts)
08/2012
1Osteoporosis
08/2012
1Thromboembolism
08/2012
1Arthralgia (Joint Pain)
08/2012
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2011
1Autoimmune Diseases (Autoimmune Disease)
11/2011
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2011
1Hepatitis C
11/2011
1Leukemia
11/2011
1Hemorrhage
11/2011

Drug/Important Bio-Agent (IBA)

6Epidermal Growth Factor Receptor (EGF Receptor)IBA
11/2014 - 06/2006
6vorinostat (suberoylanilide hydroxamic acid)FDA Link
04/2014 - 04/2009
4Phosphotransferases (Kinase)IBA
09/2015 - 01/2008
4bortezomib (Velcade)FDA Link
04/2014 - 12/2011
4irinotecan (Camptosar)FDA LinkGeneric
11/2010 - 08/2002
43-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
10/2010 - 04/2008
3TamoxifenFDA LinkGeneric
08/2012 - 01/2008
2tyrosine receptor (receptor, tyrosine)IBA
09/2015 - 06/2012
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2014 - 01/2009
2sunitinib (Sutent)FDA Link
03/2014 - 01/2008
2Paclitaxel (Taxol)FDA LinkGeneric
01/2014 - 08/2011
2gefitinib (Iressa)FDA Link
04/2013 - 04/2009
2lenalidomide (CC 5013)FDA Link
12/2012 - 12/2010
2Raloxifene (Evista)FDA Link
08/2012 - 12/2008
2Alkaline PhosphataseIBA
06/2011 - 04/2009
2gemcitabineFDA Link
02/2011 - 02/2010
2Type I DNA Topoisomerases (Topoisomerase I)IBA
11/2010 - 08/2002
2Tyrosine (L-Tyrosine)FDA Link
01/2009 - 01/2008
2trastuzumab (Herceptin)FDA Link
01/2009 - 03/2006
2DNA (Deoxyribonucleic Acid)IBA
06/2006 - 08/2005
1anaplastic lymphoma kinaseIBA
09/2015
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2015
1gossypol acetic acidIBA
04/2014
1Etoposide (VP 16)FDA LinkGeneric
04/2014
1BH 3IBA
04/2014
1pegfilgrastim (Neulasta)FDA Link
04/2014
1Cisplatin (Platino)FDA LinkGeneric
04/2014
1Serotonin (5 Hydroxytryptamine)IBA
03/2014
1bevacizumabFDA Link
03/2014
1taxaneIBA
02/2014
1oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014
1duloxetine (Cymbalta)FDA Link
01/2014
1ipilimumabIBA
07/2013
1Dacarbazine (DIC)FDA LinkGeneric
07/2013
1Dosage Forms (Dosage Form)IBA
06/2013
1Testosterone (Sustanon)FDA Link
06/2013
1N- (4- bromo- 2- fluorophenyl)- 6- methoxy- 7- ((1- methylpiperidin- 4- yl)methoxy)quinazolin- 4- amine (ZD6474)IBA
05/2013
1docetaxel (Taxotere)FDA Link
04/2013
1exemestane (Aromasin)FDA Link
08/2012
1Selective Estrogen Receptor Modulators (SERM)IBA
08/2012
1Aromatase (CYP19)IBA
08/2012
1eltrombopagFDA Link
11/2011
1Thrombopoietin ReceptorsIBA
11/2011
1Inosine Triphosphate (ITP)IBA
11/2011
1poly(lactic acid) (polylactic acid)IBA
08/2011
1Ethylene Glycol (Monoethylene Glycol)IBA
08/2011
117-(allylamino)-17-demethoxygeldanamycin (17AAG)IBA
08/2011
1MicellesIBA
08/2011

Therapy/Procedure

11Drug Therapy (Chemotherapy)
04/2014 - 08/2002
3Chemoprevention
04/2015 - 12/2008
2Adjuvant Chemotherapy
01/2008 - 07/2005
1Polypharmacy
06/2015
1Kidney Transplantation
12/2011